Study of Gefapixant (MK-7264) in Acute Cough for Participants With Induced Viral Upper Respiratory Tract Infection (URTI) (MK-7264-013)

NCT03569033 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
46
Enrollment
INDUSTRY
Sponsor class

Stopped The data did not support study endpoints for acute cough, based on an interim efficacy analysis; not due to safety concerns.

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC